Healthpeak Properties (NYSE:DOC) Price Target Raised to $23.00 at Cantor Fitzgerald

Healthpeak Properties (NYSE:DOC) had its target price hoisted by Cantor Fitzgerald from $20.00 to $23.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the real estate investment trust’s stock. Cantor Fitzgerald’s price target points to a potential upside of 5.49% from the stock’s previous close.

DOC has been the topic of several other research reports. Evercore cut Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 target price on the stock. in a research report on Monday, May 11th. Mizuho increased their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, July 6th. BMO Capital Markets increased their price objective on Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, June 15th. Citigroup increased their price target on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. Finally, Wells Fargo & Company lifted their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 15th. Four analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $20.97.

Healthpeak Properties Stock Performance

Shares of NYSE:DOC opened at $21.80 on Thursday. Healthpeak Properties has a one year low of $15.70 and a one year high of $22.95. The firm has a market cap of $15.03 billion, a PE ratio of 62.29, a price-to-earnings-growth ratio of 3.36 and a beta of 1.01. The firm’s 50 day simple moving average is $21.12 and its 200-day simple moving average is $18.76. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.87% and a net margin of 8.24%.The firm had revenue of $771.58 million for the quarter, compared to analyst estimates of $725.64 million. During the same quarter last year, the firm posted $0.46 earnings per share. The business’s revenue for the quarter was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, equities analysts predict that Healthpeak Properties will post 1.75 EPS for the current year.

Insider Buying and Selling

In other news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 0.23% of the company’s stock.

Institutional Investors Weigh In On Healthpeak Properties

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Norges Bank purchased a new stake in Healthpeak Properties in the 4th quarter valued at $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Healthpeak Properties by 694.6% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after purchasing an additional 7,007,777 shares during the last quarter. Bank of New York Mellon Corp raised its position in Healthpeak Properties by 60.3% in the first quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock valued at $253,949,000 after purchasing an additional 5,815,189 shares during the period. Fuller & Thaler Asset Management Inc. boosted its position in shares of Healthpeak Properties by 19.2% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after buying an additional 4,776,056 shares during the period. Finally, Massachusetts Financial Services Co. MA grew its stake in shares of Healthpeak Properties by 214.0% in the second quarter. Massachusetts Financial Services Co. MA now owns 4,230,551 shares of the real estate investment trust’s stock valued at $98,050,000 after buying an additional 2,883,382 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.